Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Neurotune acquires neuropathic pain projects from Brane Discovery
October 2008
SHARING OPTIONS:

SCHLIEREN, SwitzerlandóNeurotune AG, recently announced the expansion of its portfolio with two programs in neuropathic pain via a cash and share transaction with Brane Discovery Srl. The newly added projects will be focused on the most important sub-indications in the neuropathic pain market, such as osteoarthritis pain or diabetic neuropathy. The projects are in preclinical and clinical Phase 1 stage, respectively.

Andreas J. Schulze, CEO of Neurotune, says the acquisition is part of the implementation of Neurotune's strategic decision to broaden its pipeline with attractive indications in the CNS area. The large patient potential in combination with a huge need for effective therapies offers a considerable commercial opportunity. DDN

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.